Abdulaziz Kamili
Hamburg, HH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Adaptive bridging and holding therapy frequently reduces tumor burden and is associated with reduced toxicity after CAR-T cell therapy in multiple myeloma: A single-center real-world experience.
Journal: Transplantation and cellular therapy
Published: June 21, 2026
Characteristics, treatment regimens, and outcomes of patients with true extramedullary multiple myeloma: a real-world monocentric analysis.
Journal: Annals of hematology
Published: February 18, 2026
Navigating the Post-BCMA/GPRC5D Landscape: Efficacy of Selinexor, Bortezomib, and Dexamethasone After Sequential Immunotherapy Failure in Penta-Refractory Multiple Myeloma-A Multicenter Analysis.
Journal: American journal of hematology
Published: December 02, 2025
Correction: Activity of CAR-T cells and bispecific antibodies in multiple myeloma with extramedullary involvement.
Journal: Blood cancer journal
Published: November 01, 2025
Hepatitis E virus infections in people with multiple myeloma: an emerging challenge in the era of immunotherapeutic approaches.
Journal: Haematologica
Published: June 03, 2025
Activity of CAR-T cells and bispecific antibodies in multiple myeloma with extramedullary involvement.
Journal: Blood cancer journal
Published: March 11, 2025
Multiple myeloma in the young: insights on prognosis, clinical features and treatment outcome derived from nationwide German registry data and a nested multicenter sample.
Journal: Haematologica
Published: April 11, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026